Milestone Pharmaceuticals Inc. Quarterly Interest Expense in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Milestone Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from Q1 2023 to Q1 2024.
  • Milestone Pharmaceuticals Inc. Interest Expense for the quarter ending March 31, 2024 was $872K, a 2542% increase year-over-year.
  • Milestone Pharmaceuticals Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.39M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.39M $872K +$839K +2542% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.55M $860K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $841K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $820K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $33K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.